Skip to content

Effects of sevoflurane and propofol on glucose changes during operation

Changes in blood glucose during surgery laparoscopic cholecystectomy under general anesthesia with two method Remifentanil-propofol and Remifentanil-sevofluran

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012090610761N1
Enrollment
320
Registered
2013-03-03
Start date
2011-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood glucose. Hyperglycaemia,unspecified

Interventions

Intervention 1: In Group 1, infusion of remifentanil / propofol 0.1-1 µg/kg/min remifentanil 50- 150µg/kg/min-propofol is given for patient . Patient's blood glucose is meas
Treatment - Drugs
In Group 1, infusion of remifentanil / propofol 0.1-1 µg/kg/min remifentanil 50- 150µg/kg/min-propofol is given for patient . Patient's blood glucose is measured Before i
In group 2, the infusion of remifentanil / sevoflurane 0.1-1 µg/kg/min remifentanil 0.5%-2% MAC sevoflorane is given for patient . Patient's blood glucose is measured Befor

Sponsors

Jundishapur University of Medical Sciences,Vice Chancellor for Research and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Elective patients that the ASA Class1 Exclusion criteria : Course of action when conditions change Such as prolonged operative time or surgical plan changes for conversion to laparotomy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Changes in blood glucose during surgery. Timepoint: Before induction, 45 minutes later.end of operation(before extubation). after extubation. Method of measurement: With a glucometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMir ahmad hendinezhad

Ahwaz Jundishapur University of Medical Scienses

ahmadhendinezhad@yahoo.com+98 61 1336 7571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026